Delayed longitudinalmyocardial function recovery afterdobutaminechallenge as anovelpresentation of myocardial dysfunction in type 2 diabetic patients without angiographic coronary artery disease

European Heart Journal Cardiovascular Imaging

Volumn 16, Issue 6, 2015, Pages 676-683

  Wierzbowska Drabik, Karina ^a   Hamala, Piotr ^a   Kasprzak, Jarosław D ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Automated function imaging; Diabetes; Dobutamine stress echocardiography; Speckle tracking; Systolic longitudinal strain

Indexed keywords

ATROPINE; DOBUTAMINE;

ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR PARAMETERS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE; HUMAN; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MYOCARDIAL DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PEAK SYSTOLIC LONGITUDINAL STRAIN; PRIORITY JOURNAL; SPECKLE TRACKING ECHOCARDIOGRAPHY; STATISTICAL ANALYSIS; STRESS ECHOCARDIOGRAPHY; CONVALESCENCE; CORONARY ANGIOGRAPHY; ECHOGRAPHY; ELECTROCARDIOGRAPHY; PATHOPHYSIOLOGY; RADIOGRAPHY; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

ANGINA PECTORIS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; ECHOCARDIOGRAPHY, STRESS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; RECOVERY OF FUNCTION; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84942095694     PISSN: 20472404     EISSN: 20472412     Source Type: Journal    
DOI: 10.1093/ehjci/jev004     Document Type: Article

References (25)

1. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972; 30:595-602.
2. Hayat SA, Patel B, Khattar RS, Malik RA. Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci 2004;107:539-57.
3. Kreçki R, Arazińska A, Peruga JZ, Plewka M, Kasprzak JD, Krzemińska-Pakuła M. Characteristics, management and five-year outcomes of patients with high risk, stable multivessel coronary heart disease. Kardiol Pol 2014;72:262-8.
4. Ryden L, Grant PJ, Anker SD, Berne C, Cosentino F, DanchinNet al. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the task force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 2013;34: 3035-87.
5. Zhao TC, Wang M, SiuCW, Hou YL, Wang T, Tse HFet al. Myocardial dysfunction in patients with type 2 diabetes mellitus: role of endothelial progenitor cells and oxidative stress. Cardiovasc Diabetol 2012;11:147.
6. Yoon YS, Uchida S, Masuo O, Cejna M, Park JS, Gwon HC et al. Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor. Circulation 2005;111:2073-85.
7. Ng ACT, Delgado V, Bertini M, van der MeerRW, Rijzewijk LJ, Ewe SH et al. Myocardial steatosis and biventricular strain and strain rate imaging in patients with type 2 diabetes mellitus. Circulation 2010;122:2538-44.
8. Chen Y, Zhao CT, Zhen Z, Wong A, Tse HF, Yiu KH. Association of myocardial dysfunction with vitaminDdeficiency in patients with type 2 diabetes mellitus. J Diabetes Complications 2014;28:286-90.
9. Ernande L, Bergeot C, Rietzschel ER, De Buyzere ML, ThibaultH, Pignonblanc PG et al. Diastolic dysfunction in patients with type 2 diabetes mellitus: is it really the first marker of diabetic cardiomyopathy? J Am Soc Echocardiogr 2011;24: 1268-75.
10. Zoroufian A, Razmi T, Taghavi-Shavazi M, Lotfi-Tokaldany M, Jalali A. Evaluation of subclinical left ventricular dysfunction in diabetic patients: longitudinal strain velocities and left ventricular dyssynchrony by two-dimensional speckle tracking echocardiography study. Echocardiography 2014;31:456-63.
11. Guo R, Wang K, SongW, Cong T, Shang ZJ, Sun YH et al. Myocardial dysfunction in early diabetes patients with microalbuminuria: a 2-dimensional speckle tracking strain study. Cell Biochem Biophys 2014;70:573-8.
12. Roos CJ, Scholte AJ, KharagjitsinghAV, Bax JJ, Delgado V. Changes inmultidirectional LV strain in asymptomatic patients with type 2 diabetes mellitus: a 2-year follow-up study. Eur Heart J Cardiovasc Imaging 2014;15:41-7.
13. Ernande L, Bergeot C, Girerd N, Thibault H, Davidsen ES, Gautier Pignon-Blanc P et al. Longitudinal myocardial strain alteration is associated with left ventricular remodeling in asymptomatic patients with type 2 diabetes mellitus. J Am Soc Echocardiogr 2014;27:479-88.
14. CognetT, Vervueren PL, Dercle L, Bastie D, Richaud R, BerryMet al.Newconcept of myocardial longitudinal strain reserve assessed by a dipirydamole infusion using 2D-strain echocardiography: the impact of diabetes and age, and the prognostic value. Cardiovasc Diabetol 2013;12:84.
15. Cadeddu C, Nocco S, Piano D, Deidda M, Cossu E, BaroniMGet al. Early impairment of contractility reserve in patients with insulin resistance in comparison with healthy subjects. Cardiovasc Diabetol 2013;12:66.
16. Wierzbowska-Drabik K, Hamala P, Roszczyk N, Lipiec P, Plewka M, Kreçki R et al. Feasibility and correlation of standard 2D speckle tracking echocardiography and automated function imaging derived parameters of left ventricular function during dobutamine stress test. Int J Cardiovasc Imaging 2014;30:729-37.
17. Wierzbowska-Drabik K, Roszczyk N, Sobczak M, Kurpesa M, Płońska-Gosćiniak E, Kasprzak JD. Effect of sex on the diagnostic efficacy of dobutamine stress echocardiography with early atropine administration in the detection of coronary artery disease. Pol Arch Med Wewn 2014;124:105-13.
18. Szymczyk E, Lipiec P, Michalski B, Kasprzak JD. Echocardiography 2012-novel imaging modalities. Where are we now? Pol J Cardiol 2013;15:34-40.
19. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. Recommendations for chamber quantification: a report from theAmerican Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63.
20. Scholte AJHA, Nucifora G, Delgado V, Djaberi R, Boogers MJ, Schuijf JD et al. Subclinical left ventricular dysfunction and coronary atherosclerosis in asymptomatic patients with type 2 diabetes. Eur J Echocardiogr 2011;12:148-55.
21. Jellis CL, Stanton T, Leano R, Martin J, Marwick TH. Usefulness of at rest and exercise hemodynamics to detect subclinical myocardial disease in type 2 diabetes mellitus. Am J Cardiol 2011;107:615-21.
22. Boudina S, Sena S, O'Neil BT, Tathireddy P, Young ME, Abel ED. Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 2005;112:2686-95.
23. HowOJ, Aasum E, Severson DL, ChanWY, Essop MF, Larsen TS. Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice. Diabetes 2006; 55:466-73.
24. Dragoy Hafstad A, Khalid AM, How OJ, Larsen TS, Aasum E. Glocose and insulin improve cardiac efficiency and post-ischemic functional recovery in perfused hearts from type 2 diabetic (db/db) mice. Am J Physiol Endocrinol Metab 2007;292: E1288-94.
25. Mor-Avi V, Lang RM, Badano LP, Belohlavek M, Cardim NM, Derumeaux G et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE Consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. Eur J Echocardiogr 2011;12:167-205.